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The electronic health record (EHR) contains a diverse set of clinical observations that are captured as part
of routine care, but the incomplete, inconsistent, and sometimes incorrect nature of clinical data poses
signiﬁcant impediments for its secondary use in retrospective studies or comparative effectiveness
research. In this work, we describe an ontology-driven approach for extracting and analyzing data from
the patient record in a longitudinal and continuous manner. We demonstrate how the ontology helps
enforce consistent data representation, integrates phenotypes generated through analyses of available
clinical data sources, and facilitates subsequent studies to identify clinical predictors for an outcome of
interest. Development and evaluation of our approach are described in the context of studying factors
that inﬂuence intracranial aneurysm (ICA) growth and rupture. We report our experiences in capturing
information on 78 individuals with a total of 120 aneurysms. Two example applications related to assess-
ing the relationship between aneurysm size, growth, gene expression modules, and rupture are
described. Our work highlights the challenges with respect to data quality, workﬂow, and analysis of data
and its implications toward a learning health system paradigm.
 2015 Elsevier Inc. All rights reserved.1. Introduction
The promise of using electronic health records (EHRs) for sec-
ondary uses such as studying the natural evolution of diseases,
characterizing recent trends in exposures, and improving the qual-
ity and delivery of care has been well-documented [1–3]. Recent
reports from the Institute of Medicine on health information tech-
nology motivate the reuse of EHR data to achieve a learning health-
care system that permits real-time analysis of data collected about
patients [5,6]. Efforts to mine the patient record have demon-
strated promising results in identifying patient cohorts for clinical
trials [7], detecting adverse drug events [8], and providing clinical
phenotypes for correlation with genetic ﬁndings [9]. Infrastructure
tools such as i2b2 and SHARPn have made searching, summarizing,
and retrieving data from cohorts captured by the EHR more feasi-
ble [10,11]. These developments have supported a growing body of
work that utilize EHR data in identifying patient cohorts with
speciﬁc diseases and conducting large population studies to mineassociations between gene variants and clinical phenotypes
[12–14]. Nevertheless, fulﬁlling the promise of precision medicine
necessitates not only the ability to aggregate and mine information
from multiple clinical data sources, but also novel approaches to
obtain detailed characterizations of observations that provide suf-
ﬁcient context for studying the evolution of a patient’s condition.
Moreover, the results of observational studies leveraging EHR data
are inﬂuenced by inherent variability in reporting quality, which
may result in biased, incomplete, and inconsistent information
[15,16]. Sample sizes that are larger than a single institution are
frequently required to establish statistical signiﬁcance, but EHR
data are typically kept in silos that make pooling information
across multiple populations difﬁcult. Common data models such
as the Clinical Element Model (CEM) [17] and the Observational
Medical Outcomes Partnership (OMOP) [18] are beginning to
address these data integration issues, but the implementation of
these models remains limited in scope. Establishment of a compu-
tation framework and systematic workﬂow is needed to address a
number of caveats in transforming data originally collected for
clinical and billing purposes into data usable for research [19].
In this paper, an ontology-driven framework is presented for
representing and validating observational clinical, imaging, and
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is to facilitate the systematic extraction and longitudinal represen-
tation of detailed observations in a standardized manner, allowing
a large cohort of individuals to be identiﬁed from the EHR and sub-
sequently used to address research aims. The ontology plays a cen-
tral role in data integration, information extraction, quality
assessment, and retrieval.
1.1. Related work
Components of this work are similar to existing approaches, but
several distinctions can be made. In [20], Min et al. demonstrated
the application of an ontology to assist in the integration and
querying of heterogeneous information across a prostate cancer
database and tumor registry. A prostate cancer ontology was cre-
ated and mapped to multiple custom relational databases using a
mediator (D2RQ). The use of the ontology permitted queries to
be posed using the SPARQL Protocol and RDF Query Language
(SPARQL), allowing data to be easily retrieved from multiple
sources using a single query. In our work, the role of the ontology
is similar, but we demonstrate how the ontology is integrated with
the OMOP common data model, rather than formulating a custom
data model and maintaining a mapping. REDCap [21] is an elec-
tronic data capture tool that permits users to easily design and
deploy standardized forms with data validation functions.
Observations and measurements associated with each instance of
a disease are tracked independently over time in our approach,
permitting investigators to study a particular instance (e.g., evolu-
tion of a single lesion) or the patient as a whole (e.g., total number
of lesions in a patient), maintaining this distinction in REDCap is
difﬁcult using the current paradigm employed to organize its data.
OPIC (Ontology-driven Patient Information Capture) is a data col-
lection framework that utilizes the Epilepsy and Seizure ontology
to standardize data entry and representation, proactively enforce
data accuracy, and support logical skip patterns [22,23]. While
related in approach, our work focuses on using the ontology to
extract and represent clinical data; we also show how an ontol-
ogy-driven approach can be applied to another domain with differ-
ing information requirements. In summary, the contributions of
our work are threefold: (1) to present a framework that combines
the OMOP common data model with an application ontology to
integrate heterogeneous data across multiple sources; (2) to
employ the ontology as the central source of domain knowledge
to transform clinical data into a structured representation that
characterizes clinical observations longitudinally; and (3) to dis-
cuss the strengths and limitations of utilizing an ontology-driven
approach to improve the quality of data extracted from the EHR
for secondary use.
1.2. Driving example: intracranial aneurysms
As a running illustration, our efforts are described in the context
of analyzing data from patients with intracranial aneurysms (ICA).
ICAs are complex lesions that are only partially understood: their
multifaceted nature has hampered efforts to explain its pathophys-
iology and thus the development of effective therapies. Ruptured
ICAs result in subarachnoid hemorrhage (SAH) associated with a
poor 30-day mortality rate of 17–35% [24]. Recent studies on ICA
have focused on imaging studies [25], tissue samples [26], and
genomic analyses [27,28]; such studies have identiﬁed variables
(e.g., wall shear stress, familial inﬂuence, environmental factors)
that inﬂuence how ICAs form and evolve. However, these studies
typically analyze facets of the disease in isolation: while predictive
factors are reported, no study has attempted to comprehensively
understand the relationship between pathophysiological and
genetic factors with clinical observables. Hence, gaps persist inour knowledge of what is known about the disease, what areas
need to be further understood, and how the knowledge gained
can inﬂuence routine clinical decisions. One notable effort was
the @neurIST project [29], which implemented a grid-based infras-
tructure and application ontology for standardizing and sharing
data from multiple sources and analyzing the data to generate
computational models of risk for patients. While their efforts
resulted in a platform for aggregating and sharing data on a speciﬁc
patient cohort across multiple institutions, the ability to generalize
their work to other research environments has yet to be demon-
strated. Two example applications based on our developed frame-
work are described to illustrate how the ontology is helping yield
new insights into the management of this patient population.2. Materials & methods
The overarching goal in utilizing an ontology-driven approach is
to improve the quality and accessibility of clinical observations and
relevant contextual information to answer questions related to
rupture risk and treatment selection in individuals with ICA. Our
local institutional review board approved a waiver of consent for
retrospective review of past ICA cases and consent materials for
prospective cases. The following sections describe the approaches
used to formulate the application ontology, establish a data extrac-
tion and integration workﬂow, generate detailed contextual infor-
mation from the clinical data, and monitor the collection process.2.1. Intracranial aneurysm ontology
2.1.1. Scope
The Intracranial Aneurysm Ontology serves as a unifying repre-
sentation for modeling relevant ﬁndings related to ICA. The
ontology covers a broad range of information speciﬁc to aneurysm
risk, morphology, and treatment that is reported in or derived from
clinical data sources, as listed in Table 1. Information related to
biological processes is not explicitly represented in the ontology;
rather, existing ontologies such as Gene Ontology are referenced
[30]. Examples of how the ontology inﬂuences data extraction
and integration are depicted in Fig. 1. Entity names and synonyms
captured in the ontology are used to generate term lists that are
used in named entity recognition (Fig. 1a). Annotations associated
with each entity specifying data type and permissible values con-
strain how ﬁelds are presented to the user in the web-based form
(Fig. 1b). Queries that exploit the ontology’s graph structure and
semantic relationships can be executed using SPARQL to retrieve
related entities (Fig. 1c).2.1.2. Approach
Using the Basic Formal Ontology (BFO) [31] as the overarching
organization, the ontology was developed using a top-down,
bottom-up approach to catalog relevant entities, relations, and
attributes.2.1.2.1. Top-down approach. A top-down approach was followed to
identify candidate entities based on the input of clinical investiga-
tors and examination of current scientiﬁc literature. During the
elicitation process, individuals with backgrounds in neurosurgery
(NRG), interventional and diagnostic neuroradiology (FV, JPV),
and hemodynamic analysis (FV, AC) were asked to enumerate all
known variables with relevance to aneurysm growth and rupture.
In addition, a review of published systematic reviews and reporting
standards was conducted to identify relevant entities documented
in the literature [32–39]. In total, the top-down approach yielded
398 unique entities.
Table 1
Summary of variables extracted or derived from observational clinical data, the data source from which the variable was derived, and any existing vocabularies to which the
variable could be mapped.
Parent concept Concept Data source Source vocabulary
Clinical encounters
and follow-up
Demographics, diagnosis,
presentation
Age Admission and discharge summaries; surgical
reports, radiology consults
SNOMED CT, NCI
Thesaurus
Clinical presentation
Date of presentation
Ethnicity
Gender
Signs and symptoms
Family history, social history Alcohol consumption History & physical; patient self-reported
surveys
Aneurist
Smoking
Personal/family history of
chronic heart disease
Personal/family history of
diabetes
Personal/family history of
inherited disorders
Personal/family history of
other comorbidities
Neurological exam, follow-
up and outcomes
Clinical assessment Neurology consults Aneurist
Date of follow-up
Glasgow Coma Sore
Modiﬁed Rankin Scale
NIH Stroke Scale
World Federation Scale
Medications Papaverine Computerized order entry RxNORM
Triple-H
Imaging studies Image ﬁndings Arterial incorporation CT/MR angiography; radiology reports Aneurist, RadLex
Calciﬁcation
Intraluminal thrombus
Number of aneurysms
Treatment status
Morphology Anatomical location Aneurist, Foundational
Model of Anatomy
Date of scan
Dome dimension
Neck dimension
Shape
Hemodynamics Flow patterns Hemodynamic simulations from CT/MR
angiography
Wall shear stress
Genetics Peripheral blood sequencing DNA methylation Biospecimen collection Gene Ontology
RNA transcription factors
Interventions Endovascular embolization Balloon assistance Interventional neuroradiology reports SNOMED CT, Aneurist
Complications
Hospital length of stay
ICU length of stay
Stent placement
Type of embolic material
Surgical clipping Bypass type
Complications
Hospital length of stay
ICU length of stay
Temporary artery clipping
Type of aneurysm clip
Type of craniotomy
Outcome Immediate anatomic result Consult notes
Immediate clinical result
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characterize the entities that have been reported as part of stan-
dard of care and extractable from the patient record. The chart
abstraction task consisted of two parts: (1) enumeration of
variations (e.g., synonyms, abbreviations) identiﬁed during the
top-down approach as expressed in practice; and (2) identiﬁcationof new entities documented in the record that were not initially
identiﬁed through the top-down approach. Thirty retrospective
cases were identiﬁed, resulting in a total of 307 documents com-
prising neurology consults, radiology reports, inpatient admission
and discharge summaries, and referral letters. To reduce the
burden on the human annotator, an information extraction
Fig. 1. A schematic illustrating how information in the ontology was utilized in different aspects of the data extraction and representation process. The ontology was
leveraged in three ways: (a) As part of the information extraction task, entities in the ontology were used to provide terms and synonyms for the named entity recognition
component; (b) the ontology also mapped to speciﬁc ﬁelds in the web-based data entry form and provided constraints for data validation; and (c) the contents of the ontology
were queried using SPARQL to retrieve information from the underlying data model based on semantic relationships.
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Management Architecture (UIMA) [40] to identify all noun phrases
and generate mappings between these phrases to UMLS (Uniﬁed
Medical Language System) via MetaMap [41]. Of the 1341 unique
noun phrases, 261 mapped to concepts in UMLS. Upon review by
a human annotator, 85 unique entities were identiﬁed, relating
to speciﬁc interventional devices (e.g., ICA treatment coil types
such as Matrix2 360 or GDC-18 360) and documented ﬁndings
(e.g., stent-induced hyperplasia, coil compaction) that were not
brought up during the top-down elicitation process.
An initial set of semantic relationships was delineated based on
ones deﬁned by the OMOP common data model; these relation-
ships were drawn from existing terminologies such as SNOMED
CT and RxNORM. To represent semantics related to scientiﬁc inves-
tigation, additional relationships were drawn from our prior work
on the Phenomenon-centric Data Model and the Ontology for
Biomedical Investigations [42]. These relationships were reviewed
by domain experts who pruned the existing set and added relation-
ships they perceived as missing. As a result, 145 relationships (140
object properties and 5 data properties) were deﬁned.1 Accessible at http://www.mii.ucla.edu/~willhsu/icaproject2.1.3. Implementation
Protégé 4.3 [43] was used to formulate the ontology, and
webProtégé [44] was used as part of the review process, allowing
two investigators to modify the ontology through a web-based
interface. The investigators worked collaboratively, ﬁnalizing the
list of entities based on their domain expertise. The resulting ontol-
ogy is comprised of 589 logical axioms, 483 entities, 140 object
properties, and 5 data properties and has been made available inWeb Ontology Language (OWL) format.1 A breakdown of the enti-
ties represented in the ontology and whether the entities are new
or drawn from existing ontologies is provided in Table 2.
2.2. Data representation
An important requirement of the underlying representation was
to support concurrent retrospective and prospective data collec-
tion. Retrospective cases were identiﬁed based on a list compiled
by clinical investigators and patient cohort searches using diagnos-
tic codes such as ICD-9 codes 430 (Subarachnoid hemorrhage) and
437.3 (Cerebral aneurysm, nonruptured). Prospective cases were
recruited from individuals who were diagnosed with an aneurysm
and were scheduled for a consultation at our institution.
Individuals who consented to participate in the study completed
a standardized questionnaire and underwent a blood draw that
provided specimen for subsequent genetic analysis.
The database that stored information about each patient was
organized using the OMOP v5.0 common data model, which pro-
vided a standardized representation for capturing observational
data for research. OMOP was chosen because of its ability to: (1)
provide a ﬂexible representation for capturing new information
without having to change the structure of the underlying database
for different domains; (2) leverage ontologies and existing con-
trolled vocabularies to represent the content of observations; and
(3) share collected data across multiple institutions by deﬁning a
common data representation. Of the 39 tables deﬁned in the v5.0
Table 2
Number of entities in the ICA ontology broken down by source vocabulary.
Source vocabulary Concepts (%)
Aneurist 130 (26.9%)
SNOMED CT 106 (22%)
New entities that could not be mapped to other ontologies 96 (19.8%)
NCI Thesaurus 42 (8.7%)
Basic Formal Ontology 39 (8.1%)
RxNORM/MedDRA 21 (4.3%)
Foundational Model of Anatomy 20 (4.1%)
Other ontologies 15 (3.1%)
Logical Observation Identiﬁers Names and Codes (LOINC) 14 (3%)
136 W. Hsu et al. / Journal of Biomedical Informatics 55 (2015) 132–142speciﬁcation, a subset of 26 tables related to standardized clinical
data, metadata, and vocabularies were populated with data from
clinical sources as part of this work. Tables related to provider
details (e.g., standardized health system data), costs of healthcare
delivery (e.g., economics), and information about clinical events
generated from other tables (e.g., derived elements) were not pop-
ulated given the initial scope of the research questions (but will be
added as part of future work). A modiﬁcation to the OMOP model
was introduced to permit instances of observations, measure-
ments, procedure occurrences, and drug exposure to be associated
with a particular condition occurrence. The existing OMOP model
currently only associates an observation with unique person and
visit instances; observations cannot refer to speciﬁc condition
instances. An example of this limitation is if a patient has two dis-
tinct aneurysms with measurements taken of each aneurysm. The
current model does not support uniquely associating a measure-
ment to a speciﬁc aneurysm. Hence, additional foreign keys were
deﬁned between observations and measurements allowing them
to reference a speciﬁc condition occurrence.
OMOP was also selected because of the incorporation of stan-
dardized vocabularies to represent the content of observational
data. The design of the data model is a hybrid between entity-rela-
tionship (ER) and entity–attribute-value (EAV) models. In OMOP,
new information collected or derived from the patient record can
be captured by adding entities to the vocabulary without changing
the structure of the database. Researchers collect information
about new variables by specifying a corresponding entity to the
ontology, which in turn augments the possible entities and values
that are captured by the database. This approach allows the data-
base to adapt to changes in data collection by adding or modifying
entities in the ontology through a web-based interface, reﬂecting
these changes immediately in the data entry and querying compo-
nents of the workﬂow. An ongoing challenge is ensuring the con-
sistent usage of a given entity to represent clinical information
across individuals or institutions; an established method has been
to create data dictionaries at each institution that are then mapped
and harmonized to standard terminology resources [45]. The ICA
ontology developed at our institution is used to populate the stan-
dardized vocabulary tables in the OMOP common data model, dic-
tating how values extracted from observational clinical data are
encoded.
2.3. Analysis workﬂow
The analysis workﬂow is illustrated in Fig. 2. Each patient case is
analyzed along four perspectives: clinical (patient demographics,
presentation, treatment, follow-up), quantitative imaging (3D
morphological analysis), hemodynamics (computational ﬂuid
dynamics), and whole genome sequencing (weighted gene co-
expression network analysis) on individuals who provided blood
samples. Once patient data is retrieved and entered into the
research repository, investigators involved in each aspect of theanalysis are notiﬁed of pending cases. Characterization of each data
type is described in the following paragraphs.2.3.1. Clinical
Initially, data entry was performed by two human annotators (a
resident and a research associate) who reviewed each case, enter-
ing information into a web-based form. A neurosurgery fellow pro-
vided oversight to ensure the validity of annotations being
generated. Given the number of variables being collected (summa-
rized in Table 1), a UIMA pipeline was developed to automate the
information extraction process. Annotators targeted reported mea-
surements along different axes (e.g., anteroposterior, cranio-cau-
dal), characteristics about the aneurysm (e.g., shape), clinical
presentation (e.g., subarachnoid hemorrhage, incidental aneur-
ysm), anatomical location, and interventions (e.g., whether an indi-
vidual underwent stent-assisted coiling). A combination of regular
expressions, dictionary lookup, and rule-based methods were used
to implement each annotator, depending on the complexity of
information being targeted. Entities and their synonyms drawn
from the ontology were incorporated into term lists that were
utilized in the lookup process. For example, to identify mentions
of aneurysm location, all child entities of ‘‘aneurysm location’’
and their synonyms were retrieved. During the development
process, the UIMA pipeline performed a ﬁrst-pass review of
each case with the human annotator validating the results and
committing them to the database.2.3.2. Quantitative image analysis
Computed tomography angiography (CTA) and magnetic reso-
nance angiography (contrast-enhanced MRI, time-of-ﬂight MRA)
provided three-dimensional, in vivo characterization of the aneur-
ysm location and morphology. For this study, all MRA and CTA
studies acquired were considered for analysis. For each imaging
study, a trained specialist utilized the Vitrea Enterprise Suite
(ViTAL Images, Minnetonka, MN), an image processing worksta-
tion, to generate volume-rendered reconstructions of the angiogra-
phy data and perform measurements along three dimensions.
Other ﬁndings of interest such as arteriovenous malformations
(AVMs), calciﬁcations, thrombi, and geometry were interpreted
by the specialist and recorded as part of semantic labels assigned
to each study. As depicted in Fig. 1, the ontology captured each
imaging study as individual instances that were semantically
related to other entities such as aneurysm location, shape, and
morphology. Morphology was characterized by entities represent-
ing measurements related to the size and orientation of the aneur-
ysm dome and neck. Measurements could then be obtained for
individual aneurysms by querying the ontology to return all
instances of aneurysm morphology related to the imaging history
associated with that aneurysm.2.3.3. Hemodynamics
CTA studies were also analyzed using a computational ﬂuid
dynamic simulation developed by collaborators (FV, AC) [46–48].
For each individual, the angiography data was used as the input
to the simulation; based on the numerical output, a researcher
(AC) assigned semantic labels to describe the blood ﬂow character-
istics (e.g., stability, pattern, division, impact, concentration).
Numerical values reﬂected wall shear stresses at six different mea-
surement points. As our institution was one of the ﬁrst to report on
these types of blood ﬂow characteristics, our clinical investigators
deﬁned the controlled terms used to characterize the blood ﬂow.
Corresponding entities were added to the ontology, permitting
the integration of hemodynamic simulation results.
Fig. 2. The analysis workﬂow. Routinely generated clinical data were captured on retrospective and prospective cases. Each case was augmented with additional image
processing and genetic analyses performed ofﬂine. The entire process was organized using a central ontology that linked with an OMOP-based database and a web-based
dashboard.
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Samples taken from prospective study participants who con-
sented to providing blood were stored in a 80 C freezer within
24 h of extraction and sent to a sequencing core and sequenced
using a 100-bp RNAseq protocol on Illumina HiSeq 2000 equip-
ment. The resulting data were aligned using the STAR RNA-seq
sequence alignment program [49]. The aligned sequences were
then used to generate a weighted gene co-expression network
(WGCNA) following a protocol similar to [50] developed by our
genetics collaborator (PP). Using demographic and family history
information from the database, gene expression values were cor-
rected for ancestry informative markers. The WGCNA identiﬁes
co-expression networks that capture the main patterns of varia-
tion. Using WGCNA, the initial set of 16,535 genes measured was
reduced to 30 modules by clustering them functionally. These
modules were then correlated with clinical phenotypes such as
aneurysm size, growth, and rupture.
2.4. User interface
2.4.1. Data entry
A web-based application was developed to facilitate the multi-
ple users inputting data. The interface consisted of a series of struc-
tured forms organized by patient, aneurysm, and observation. Each
observation was associated with a patient, condition occurrence
(e.g., each instance of an aneurysm), and visit, allowing collected
values to be summarized at the patient-level (e.g., how many
aneurysms does an individual have) or observation-level (e.g.,
how many measurements does a speciﬁc aneurysm have). In addi-
tion, information that overlapped across sources (e.g., radiology
report versus image analysis) were maintained separately, allow-
ing investigators to assess whether measurements taken of the
same aneurysm using different methods varied signiﬁcantly.
2.4.2. Research dashboard
An administrator oversaw the entire collection effort through a
web-based dashboard, as depicted in Fig. 3a. The interface pro-
vided a summary about individual cases, including whether the
analysis workﬂow had completed, whether the inputted informa-
tion was validated, and whether biospecimens and sequencingdata were available for that individual. Using relationships deﬁned
in the ontology (e.g., is-a, part-of), the dashboard grouped entities
that were related to a given ﬁnding together, which allowed inves-
tigators to determine what information was missing or inconsis-
tent. For example, at each imaging observation, measurements of
aneurysm dome size along the three axes could be derived from
the radiology report or volumetric image analysis. However, differ-
ences in measurements existed when comparing the values of
these two sources depending on the perspective and tool selected
by the individual performing the analysis. The dashboard high-
lighted these differences and missing values (e.g., if a dimension
could not be measured because of an image artifact) to the user.
Administrators had the ability to view all of the data on the entire
population and were able to edit or delete information for any of
the modules, as necessary. Other types of users who viewed the
dashboard were presented with a tailored version of the interface
with a limited set of functions. For example, researchers not
involved in the collection of the data were presented with a
read-only, de-identiﬁed view of the collected information and a
basic set of ﬁlters for cohort identiﬁcation; only aggregate statistics
about the population, not individual information such as patient
names and speciﬁc dates of procedures, were made available. For
approved investigators, the research dashboard facilitated patient
cohort identiﬁcation by providing users with a graphical interface
for formulating SPARQL queries using the entities and relationships
deﬁned in the ontology. The default ﬁlters (Fig. 3b) allowed users
to pose queries such as retrieve all cases involving female individuals
who have undergone an endovascular coiling and have imaging
follow-up. The list of available ﬁlters and permissible values were
directly drawn from entities in the ontology. Once the appropriate
patient cohort had been found, the export functionality (Fig. 3c)
allowed users to specify the variables that were included and
whether aggregate values at the patient level or observations at
the aneurysm level were returned.3. Results
The following sections describe the beneﬁts and challenges of
developing an ontology-driven framework for representing obser-
vational data and two applications illustrating the role of the
Fig. 3. A screen capture of the progress dashboard. (a) Users viewed the entire status of the analysis workﬂow and what information is available for each case from the
dashboard. (b) Built-in ﬁlters permitted users to easily search for cases that have matching characteristics. A predeﬁned set of reports was also provided, allowing users to
generate visualizations such as the one shown in Fig. 4 in real-time. (c) The export option allowed users to retrieve relevant information about matching patients in a format
that was amenable for analysis in external programs such as R.
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applying the described framework to the analysis of 78 patient
cases (30 prospectively consented cases and 48 retrospective
cases).
3.1. Role of the ontology
3.1.1. Data representation
The ontology played a central role in extracting and integrating
observational clinical data for research. Entities in the ontology
deﬁned what information was collected (or extracted) from the
patient record and provided relevant context (e.g., synonymous
terms) for standardizing the collected data. The underlying data
model was domain-agnostic, relying on the application ontology
to provide tailored knowledge for executing speciﬁc queries.
While manual modiﬁcations were necessary to revise data entry
forms to accommodate new entities, future development will per-
mit the web-based interface to dynamically adapt to reﬂect any
changes to the ontology.
3.1.2. Data quality
The collected observational data had inconsistencies in data
quality and level of granularity. For instance, the exact location
of each aneurysm was often not explicitly reported in clinical doc-
uments but was determined by reviewing the medical images. In
only a small fraction of cases, the record included survival informa-
tion for individuals who had died from aneurysm rupture, but most
individuals were lost to follow-up. In addition, some desired infor-
mation was not explicitly reported. Neurological scores (e.g., Hunt
and Hess score [51]) for individuals who presented with a rupture
were only reported in a small percentage of cases. Subsequent
review of the data by a trained individual was required to deriveestimates for these scores based on documented evidence.
Nevertheless, without explicitly reporting such information, ambi-
guity was introduced into the information extraction process. The
ontology assisted in data validation tasks in two ways. First, each
entity was deﬁned with a set of annotation properties, which spec-
iﬁed attributes such as source (e.g., original vocabulary from which
the entity is derived), valid values (e.g., enumerated responses that
are permissible), synonyms (e.g., for linking terms with the same
meaning), permissible data types (e.g., text, number, date) and def-
inition (e.g., the formal meaning of the entity). As illustrated in
Fig. 1b, these annotations were reﬂected in the web-based inter-
face where ﬁelds related to a speciﬁc entity were constrained to
only accept predeﬁned values (i.e., drawn from the list of valid
values) or for input ﬁelds, the appropriate data type (i.e., as speci-
ﬁed by the data property). Second, the ontology provided a basis
for formulating structured reporting templates that can be used
clinically. Clinical documents related to aneurysm treatment and
follow-up were largely unstructured, complicating efforts to track
individual aneurysms over time. Feedback from the research dash-
board that summarized the percentage of missing information for a
given entity (e.g., what proportion of patients have smoking his-
tory reported) can be used to guide reporting improvement initia-
tives. As part of ongoing work, we are working collaboratively with
the clinical investigators to (automatically) develop reporting tem-
plates for intracranial aneurysms based on the developed ontology.
3.2. Information extraction
The performance of the information extraction pipeline was
evaluated based on the identiﬁcation of anatomical location,
aneurysm shape, interventions, measurements, and clinical pre-
sentation from free-text reports. The evaluation was performed
Table 3
Information extraction performance for each category of information. TP, true positive; TN, true negative; FN, false negative.
Feature Type TP TN FP FN Precision Recall F-score Accuracy
Anatomical location 452 436 2 26 0.99 0.94 0.97 0.97
Morphology 40 872 0 4 1.0 0.91 0.95 0.99
Intervention 332 566 18 0 0.95 1.0 0.97 0.98
Measurement 114 790 0 12 1.0 0.98 0.99 0.99
Presentation 124 790 0 2 1.0 0.98 0.99 0.99
Fig. 4. Visualization that summarizes available observations of individual aneurysms for a subset of patients plotted by days since presentation. Observations are represented
as circles, whose size is proportion to aneurysm diameter. Such visualization can be generated in real-time from the database to track changes in aneurysms among followed
individuals.
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unseen prospective cases. Documents from which sentences were
identiﬁed included radiology reports, operative reports, consulta-
tion notes, and admission/discharge summaries. For each sentence,
the pipeline was used to highlight entities along with associated
values (e.g., aneurysm dome size and numerical dimensions); sen-
tences without any detected information were also presented. A
single human annotator than manually reviewed each of the
sentences to verify whether the highlighted entities were indeed
correctly categorized or sentences without identiﬁed entities did
not contain relevant information. Table 3 summarizes the system
performance using metrics such as precision, recall, f-score, and
accuracy. Overall, the annotators were able to consistently extract
the targeted information with high precision. Extracting clinical
presentation achieved the highest recall given the relatively
constrained nature of the terminology used (e.g., incidental versus
subarachnoid hemorrhage). Measurements had the lowest recall
(0.90) and f-score (0.95) because several values were not captured
by the employed regular expression pattern. Anatomic location
had lower accuracy (0.97) given its high number of false negatives,
demonstrating the difﬁculty of consistently detecting variations in
location names. To improve recall rates, annotators for aneurysm
location, interventional complications, and clinical assessment will
be implemented using conditional random ﬁelds (using Mallet
[52]) rather than relying solely on syntactic or lookup-based
approaches based on the degree of variability in the way terms
are expressed. While this approach may decrease overall precision,
a human annotator is ultimately responsible for ﬁnalizing and
curating cases before being entered into the database.
3.3. Example applications
3.3.1. Aneurysm morphology and rupture
Several of the authors (JPV, NRG, FV) recently published a study
on the natural history of asymptomatic unruptured ICAs, which
followed 165 individuals with 258 aneurysms over a period of
10 years. The study found that risk of aneurysm rupture was signif-
icantly increased with growth (2.4% per year) versus those that
remained unchanged (0.2%) [29]. The ﬁndings underscored the
importance of methodically capturing temporal information about
individuals to elucidate factors that affect clinical outcomes of
long-term diseases such as ICA. The original data collection andanalysis was performed using a single spreadsheet that contained
a series of columns representing measurements for each dimen-
sion. Maintaining and utilizing this spreadsheet for analysis proved
to be a time-consuming process because new columns were added
for each observation. The ontology-driven approach simpliﬁed the
tracking and analysis of individual aneurysm measurements. The
ontology contained entities representing diameters across three
measurement axes. Each dimension entity is related to the entities
‘‘dome size’’ and ‘‘neck size’’ through the relationship ‘‘has mea-
surement’’. The entity ‘‘dome size’’ is semantically related to
‘‘aneurysm morphology’’, which is in turn associated with the ﬁnd-
ing ‘‘aneurysm’’. Given these relationships, a SPARQL query can be
used to retrieve all measurements for an aneurysm of interest.
Using a combination of SPARQL queries, metrics could be automat-
ically generated from the database. For example, the average fol-
low-up time for these cases was 26.9 months (minimum: 1,
maximum: 98). The ABC/2 method [53] was used to estimate
aneurysm volume and assess for growth, accounting for measure-
ment error when utilizing the image processing software.
Examining the evolution of the 120 aneurysms in our dataset, 97
aneurysms remained unchanged while 23 enlarged in size. To date,
two aneurysms that were followed had ruptured: one non-growing
aneurysm and one growing aneurysm. As new cases and follow-up
information are added to the database, rupture rate based on char-
acteristics such as aneurysm shape, location, size, and growth can
be assessed in real-time. Fig. 4 demonstrates how linked observa-
tions can be represented as a bubble plot where the horizontal axis
represents time and the visual appearance represent the number
and sizes of aneurysms for a given patient. Additional events
drawn from the patient record could be overlaid to provide con-
text. In summary, this example application illustrated how the
ontology assisted in the organization and semantic retrieval of
information from the database, allowing researchers to easily track
and retrieve longitudinal measurements for analysis.
3.3.2. Genes and pathways involved in aneurysm rupture
The second example utilizes the database to support explora-
tory analysis of human whole blood transcriptomes with clinical
and imaging phenotypes to identify WGCNA modules associated
with aneurysm size and rupture. An initial batch of 12 individuals
with blood samples was identiﬁed from the database to perform a
pilot study, isolating and sequencing their RNA. The goal was to
Table 4
The contribution of the approach in addressing different categories of data quality, as
adapted from [4].
Domains Description Proposed approach
Correctness Whether observations
accurately reﬂect the true
state of a patient
For each observation, the
ontology captures not only
the observed value but also
annotations related to the
unique deﬁnition of a given
entity, permissible values
and data types, and source of
the information. Basic
provenance information is
also captured
Plausibility Whether an observation
makes sense in the context
of other observations
Concordance Whether independent
observations are in
agreement and reliable
Data from different clinical
sources is semantically
related based on patient,
medical problem, states,
ﬁndings, and observations.
This organization allows
values for a given entity to
be linked and assessed to
determine the level of
concordance
Currency Whether an observation is a
relevant representation of
the patient at a given time
point
Given that observations are
grouped together temporally
into states, the recency of
observations can be
evaluated. In addition,
observations made during
the time of biospecimen
collection can be identiﬁed,
providing the appropriate
context for interpreting the
results of gene expression
analysis
Completeness Whether an observation is
present or absent, as
expected
Once mapped to the
ontology, the level of missing
or discordant information in
any given data source can be
measured, allowing the
overall data quality to be
characterized
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using RNA sequencing data, genetic variant data, and clinical phe-
notypes. From the set of 16,535 genes, 30 functionally related gene
modules were enriched through WGCNA analysis using annota-
tions provided by Gene Ontology. The hierarchical structure of
the ICA ontology facilitated the retrieval of clinical phenotypes
for the correlation network analysis. For example, in the absence
of the ontology, queries that speciﬁed particular columns in the
database were needed to retrieve all of the relevant clinical values.
With the ontology, parent–child relationships were exploited to
identify relevant entities. For example, to identify values related
to family history, a SPARQL query was written to return child enti-
ties of ‘‘Family History’’ yielding entities such as ‘‘Family History of
Arteriovenous Malformation’’ and ‘‘Family History of Diabetes’’.
These results were used to identify matching rows in the observa-
tional table of the OMOP common data model. Further, because
RNA expression is inﬂuenced by environmental factors, contextual
information related to the environment and patient state at the
time of blood collection needed to be captured. In the ontology,
observations were annotated as being static or time-dependent.
Unchanging entities such as patient demographics and medical
history were semantically grouped as part of a static patient con-
text. Time-dependent entities such as aneurysm size and rupture
status were grouped as part of an aneurysm context. These seman-
tic groupings aided in the identiﬁcation of entities that may have
changed after the date of specimen collection. The list of gene
modules and clinical phenotypes were then used as inputs into a
Fisher’s exact test to determine whether relationships between
gene modules and clinical phenotypes had statistical signiﬁcance.
Down regulation of two transcript modules were correlated with
ruptured ICA status (r = 0.78, p = 0.008 and r = 0.77, p = 0.009)
while up-regulation of two cellular respiration and translation
modules were associated with aneurysm size (r = 0.86, p = 0.002
and r = 0.9, p < 0.001) [54]. This example demonstrated how the
structure of the ontology simpliﬁed retrieval of information from
the database. Further study is necessary to validate the inﬂuence
on these two transcript modules.4. Discussion
Our experience in deploying an ontology-driven approach for
characterizing and analyzing data captured routinely in the EHR
has demonstrated the promise of utilizing such information to
generate a detailed set of clinical phenotypes for subsequent
clinical-genomic analyses. Despite the inherent shortcomings of
observational data, the ability to query the resulting repository and
utilize the ontology to address certain limitations has been useful.4.1. Strengths and limitations
The described ontology-driven approach addresses issues
related to the extraction, representation, and validation of clinical
observational data for research. First, the ontology provides a cen-
tralized source for deﬁning variables to be captured, how each
variable is represented, what variables already exist in other con-
trolled vocabularies, and explicit deﬁnitions of relationships
between variables and permissible values. Second, using the
domain knowledge encoded in the ontology, data quality issues
that are inherent in clinical data can be identiﬁed, if not addressed.
Table 4 summarizes how the ontology is being applied to handle
various dimensions of data quality assessment [4]. Finally, the
usage of ontologies facilitates the integration of multiple data
sources by explicitly modeling the relationships between variables
and providing a formal means to query across distributed sources
using SPARQL. Several limitations should be noted. The creationand maintenance of an ontology is a signiﬁcant undertaking,
requiring a series of meetings among investigators to come to a
consensus about the variables and properties to collect. These dis-
cussions yielded useful insights on deﬁning the scope of the data
collection and improving the consistency of how observational
data was represented. The exercise of formulating the ICA ontology
also helped identify variables that were important risk factors in
aneurysm rupture as reported in current literature. A second limi-
tation is that the presented approach remains an indirect way to
improve clinical data capture, given that the ontology is not
directly integrated with the EHR and does not inﬂuence the data
entry interfaces that are directly utilized by healthcare providers.
While the ontology and infrastructure can quickly identify incon-
sistencies in data entry and missing information, the ontology does
not prevent such events from happening at the time of data input.
Nevertheless, this process has been informative to clinicians who
can measure the conformance rates to current reporting standards,
providing feedback as to what information needs to be more con-
sistently reported or sources of measurement error. Finally, not all
data collection projects are ideally suited for this approach.
Existing tools such as REDCap require less upfront development
and provide sufﬁcient validation and reporting tools. However,
projects that require the integration of multiple heterogeneous
and unstructured clinical data sources and require access to
detailed clinical observations will beneﬁt from the consistency,
preciseness, and domain-awareness permitted through this
approach.
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The described efforts underscore the need for more accurate
methods for data capture and representation, particularly as stud-
ies move toward longitudinal rather than cross-sectional analysis.
Combining retrospective and prospective cases as part of a single
research study presents unique challenges. While the review of
retrospective cases helped increase sample sizes for analysis and
provided cases that had long-term follow-up, issues arose when
integrating this information with prospective data without appro-
priate context. For example, measurements of aneurysm size using
acquisition protocols and image analysis software from ten years
ago differed from measurements taken of the same aneurysm
using today’s technology. These differences could incorrectly have
indicated a signiﬁcant change in aneurysm size when the varia-
tions were not signiﬁcant in reality. Furthermore, reporting style,
available diagnostic tests, and interventions all evolved over time.
For instance, the inﬂuence of dome direction on the success of
endovascular coiling was not well understood until the past ﬁve
years. While older radiology reports omit this information, more
recent reports documented dome direction as an indicator of treat-
ment success. Care must be given in recording the context in which
measurements are taken (e.g., what imaging modality was used,
whether the measurement was taken pre/post treatment). The
ontology encoded basic information related to data provenance
that permitted investigators to determine the source of the mea-
surements and methods used to derive speciﬁc values. For exam-
ple, data properties such as ‘‘has lower bound’’ and ‘‘has upper
bound’’ were deﬁned to capture uncertainty related to aneurysm
measurements made using a speciﬁc software tool based on spec-
iﬁcations provided by the manufacturer. Ongoing work is address-
ing the need to capture additional layers of provenance
information.
Moreover, being able to precisely track individual ﬁndings (e.g.,
aneurysms, lesions, nodules) over time is critical, particularly as
the technology to identify and characterize precise locations and
minute changes in the biology of these ﬁndings are translated
and adopted clinically. While current clinical documentation has
generally been sufﬁcient to perform coreference resolution of ﬁnd-
ings over time, the process of tracking ﬁndings would be greatly
facilitated by identifying unique characteristics at the outset that
are easily identiﬁable by individuals reporting or analyzing the
clinical data. In a small percentage of cases, we needed to manually
review source data (e.g., imaging studies) to verify the location of
each reported aneurysm (e.g., in cases where laterality of the
aneurysm was not documented in the reports). Our blood collec-
tion is being expanded to obtain samples from individuals as part
of their routine blood work to provide new insights into how their
transcriptome changes as the aneurysm evolves over time. While
results of this initial study are promising, we are continuing to
collect prospective cases to increase our sample size to achieve
more signiﬁcant statistical power to validate the clinical signiﬁ-
cance of the identiﬁed modules.
Nevertheless, a longstanding difﬁculty of longitudinal data
analysis is inferring what occurs between time points. Patients
may have multiple healthcare providers who may not be part of
the same health system. Data captured during an encounter with
that provider (e.g., assessment of neurologic state) may not be
recorded until the patient is seen again at our institution. A mech-
anism to routinely follow-up with treated patients would provide
important insights into the environmental and lifestyle factors that
inﬂuence aneurysm recurrence. Ultimately, a broader framework
involving a national-level learning health system, as motivated in
[55], would be beneﬁcial toward improving the quality and cover-
age of clinical information about individuals. A strength of utilizing
ontologies to standardize the representation of observational datais the ability to interoperate across geographically separated data-
bases. SPARQL queries may be formulated to retrieve instances of
entities from different knowledge sources. For instance, semantic
queries can be executed against clinical data obtained at our insti-
tution and other resources such as the @neurIST project or public
data repositories. The implementation of a federated database is
left for future work but would be modeled after similar efforts [56].
4.3. Generalizability
While demonstrated in the domain of ICA, this approach can be
generalized and scaled to other domains as well. The underlying
OMOP common data model is domain-agnostic, allowing the
schema to be reused across domains. Modiﬁcations to the applica-
tion ontology will be needed to ensure that the standardized
vocabulary reﬂects the domain being captured; this process pre-
sents the most labor intensive step in adapting and scaling the
entire workﬂow. Still, given the modular architecture of the sys-
tem, additional analyses can be incorporated by deﬁning new enti-
ties in the ontology or linking to other external sources. The
research dashboard automatically displays ﬁlters based on entities
in the ontology and in the future will dynamically update the
forms based on modiﬁcations to the ontology. Currently, only basic
provenance information is addressed in this work. Expanding the
capture of semantic provenance is critical, particularly in interpret-
ing derived information. For instance, results of the information
extraction process and quantitative image analysis need to be sup-
plemented with the steps used to generate such information (e.g.,
what workﬂow pipeline was used to extract the observed value).
We are exploring workﬂow management tools such as Taverna
[57,58] and semantic domain-aware provenance models like
Janus [59] to capture intermediate results at each processing step.
4.4. Future work
As part of future work, extraction of newer cases from the EHR
will continue toward providing additional statistical power to
validate the pilot imaging-genomic correlation study. Newer – omics
techniques (e.g., DNA methylation studies) are also being pursued to
provide new perspectives on a disease. Finally, this paradigm is
being applied to other domains at our institution, namely in the con-
text of lung cancer screening and prostate cancer diagnosis, utilizing
the longitudinal data aggregation tools and workﬂow established to
precisely characterize clinical phenotypes and image ﬁndings over
time for individuals who are at risk for cancer.5. Conclusion
We have presented an ontology-driven data integration and
analysis workﬂow that facilitates secondary analysis of observa-
tional data collected during routine patient care. We have demon-
strated two applications of how this approach assists in the
consistent data capture and representation of patient information
and facilitates data integration across sources to glean new insights
into a complex disease.
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